Search results for "LOD"

showing 10 items of 4833 documents

Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases

2013

Studies in preclinical models have demonstrated the superior anti-tumor effect of CpG oligodeoxynucleotides (CpG-ODN) when administered at the tumor site rather than systemically. We evaluated the effect of aerosolized CpG-ODN on lung metastases in mice injected with immunogenic N202.1A mammary carcinoma cells or weakly immunogenic B16 melanoma cells. Upon reaching the bronchoalveolar space, aerosolized CpG-ODN activated a local immune response, as indicated by production of IL-12p40, IFN-γ and IL-1β and by recruitment and maturation of DC cells in bronchoalveolar lavage fluid of mice. Treatment with aerosolized CpG-ODN induced an expansion of CD4+ cells in lung and was more efficacious tha…

CD4-Positive T-LymphocytesLung NeoplasmsInterleukin-1betaMelanoma ExperimentalAntineoplastic AgentsInterferon-gammaMiceCell Line TumorAnimalsHumansNeoplasm MetastasisAerosolsInterleukin-12 Subunit p40cpg-odnlung cancer microenvironment inflammationlung metastasesDendritic CellsGene Expression Regulation NeoplasticMice Inbred C57BLOligodeoxyribonucleotidesFemaleaerosol deliveryClodronic Acidaerosol delivery; cpg-odn; lung metastases; miceImmunosuppressive AgentsNeoplasm Transplantation
researchProduct

5(4H)-Oksazolonu iegūšana no cisteīna

2018

5(4H)-Oksazolona iegūšana no cisteīna. Štrāla S., zinātniskais vadītājs Dr. ķīm., doc. Kļimenkovs I. Kursa darbs organiskajā ķīmijā, 39 lappuses, 10 attēli, 5 tabulas, 32 literatūras avoti, 4 pielikumi. Latviešu valodā. Darbā ir apkopota informācija par cisteīna īpašībām, cisteīna aizsarggrupām, oksazolonu sintēzi un īpašībām, kā arī par oksazolonu Štegliha pārgrupēšanos. Eksperimentālajā daļā ir veikta vairāku cisteīna atvasinājumu sintēze, ko var izmantot tālākās reakcijās oksazolonu iegūšanai.

CISTEĪNSCIKLODEHIDRATĒŠANAŠTEGLIHA PĀRGRUPĒŠANAAMINOSKĀBJU ACILĒŠANAĶīmijaOKSAZOLONI
researchProduct

Matemātikas un angļu valodas integrētās mācības 11.klasē

2017

Pasaules kontekstā vārds „integrācija” jau ir zināms gadu desmitiem. Daudzas lietas un procesi ir integrēti, lai sasniegtu labākus rezultātus un izsekotu laika (gadsimta) un kultūras prasībām. Lielākā daļa cilvēku neievēro divas vai vairākas atsevišķas daļas no integrētā procesa, viņi to uzskata par vienotu veselumu. Lai noskaidrotu, kā jāorganizē matemātikas satura un angļu valodas integrētās apguves process 11.klases skolēniem, sporta ģimnāzijā tika veikts gadījuma pētījums. Ar mērķi noskaidrot, kā matemātikas un angļu valodas integrētās mācīšanas un mācīšanās procesu var īstenot un praktizēt darbā ar 11.klases skolēniem sporta ģimnāzijā, tika izveidotas dažādas aktivitātes un materiāli u…

CLILPedagoģijaIntegrationContent and languageSatura un valodas integrētā apguveMācīšana un mācīšanās
researchProduct

Effect of tiotropium/olodaterol combination therapy on long-term heart rate and blood pressure in COPD patients

2018

Introduction: Cardiovascular (CV) comorbidities are common in COPD, and associated with poor prognosis. LABAs and LAMAs are established COPD treatments whose pharmacology would suggest the potential to increase heart rate (HR) and impact blood pressure (BP). However, previous studies indicate that HR and BP are not negatively influenced by tiotropium (Tio) or olodaterol (Olo) monotherapy. Aims: To determine the effect of dual bronchodilation with Tio/Olo (T/O) on HR and BP. Methods: The 52-week, Phase III TONADO® studies (NCT01431274/NCT01431287) evaluated T/O 5/5 µg, Tio 5 µg or Olo 5 µg, via the Respimat® inhaler, in GOLD 2–4 COPD patients. In this post hoc analysis, long-term changes fro…

COPDmedicine.medical_specialtyCombination therapybusiness.industryCopd patientsInhalerOlodaterolmedicine.disease3. Good health03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBlood pressure030228 respiratory systemchemistryInternal medicineHeart ratePost-hoc analysismedicineCardiology030212 general & internal medicinebusinessAirway pharmacology and treatment
researchProduct

Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on β-blockers

2015

Introduction: The efficacy and safety of a new once-daily (QD) fixed-dose combination (FDC) with tiotropium (T), a long-acting muscarinic antagonist, and olodaterol (O), a long-acting β 2 -agonist, was established for the treatment of COPD in the TONADO studies (NCT01431274; NCT01431287). This analysis evaluates the efficacy of the FDC in a subpopulation of patients receiving β-blockers (BBs) in these studies. Methods: Two replicate, randomised, double-blind, parallel-group, 52-week, Phase III trials assessed the efficacy and safety of T+O FDC (2.5/5 μg; 5/5 μg; Respimat ® inhaler) QD compared to the monocomponents. Key primary end point data for the combined analysis of the replicate trial…

COPDmedicine.medical_specialtyRespimatbusiness.industryInhalerOlodaterolFixed-dose combinationMuscarinic antagonistmedicine.diseasechemistry.chemical_compoundchemistryInternal medicinemedicinePhysical therapyClinical endpointIn patientbusinessmedicine.drug5.1 Airway Pharmacology and Treatment
researchProduct

THERMOSENSITIVE CATIONIC BLOCK COPOLYMER AND CYCLODEXTRINS. INCLUSION COMPLEXES IN SOLUTION AND IN SOLID STATE

2010

COPOLYMERCYCLODEXTRINS
researchProduct

Flow cytometry diagnosis in myelodysplastic syndrome: Current practice in Latin America and comparison with other regions of the world

2019

Background: Flow cytometry (FC) is a valuable tool for the diagnosis of myelodysplastic syndromes (MDS). We present results of a survey carried out to evaluate FC current practice for MDS diagnosis in Latin America (LA), focusing on markers used and characteristics of the clinical diagnostic report. Compliance to IMDSflow recommendations was also evaluated. These practices were then compared with those used in other countries. Methods: An online survey was sent through the Grupo Latino-Americano de Mielodisplasia to LA cytometrists and other international scientific societies. Results: 91 responses from 15 LA countries were received. The median of the number of markers used was 20 +/- 4.5, …

CanadaCancer Researchmedicine.medical_specialtyAsiaLatin AmericansOceaniaImmunophenotyping03 medical and health sciencesEuropean LeukemiaNet0302 clinical medicineSurveys and QuestionnairesDiagnosismedicineHumansFlow cytometryPractice Patterns Physicians'SurveyGeographybusiness.industryMyelodysplastic syndromesHematologyFlow Cytometrymedicine.diseaseUnited StatesEuropeClinical PracticeLatin AmericaOncologyCurrent practiceMyelodysplastic Syndromes030220 oncology & carcinogenesisFamily medicineAfricabusinessMyelodysplastic syndromeBackground flowBiomarkers030215 immunologyLeukemia Research
researchProduct

Kanādas reāliju etimoloģiskā analīze

2015

Pētījuma mērķis ir analizēt Britu Kolumbijas kultūras reālijas. Aprakstoša pētījuma metode ir izvēlēta,lai sasniegtu izvirzītu mērķi un atbildētu uz pētījuma jautājumiem. Pētījums sastāv no divām galvenajām daļām. Pētījuma teorētisko daļu attēlo divas nodaļas. pirmā nodaļa fokusējas uz dažādām kultūras reāliju klasifikācijas pieejām. Otrā nodaļa ir domāta toponīmu pētījuma esoša korpusa apspriedei un mēģinājumiem klasificēt Kanādas toponīmus. Trešā nodaļa, kas ir pašreizējā pētījuma empīriskā daļa, ietver izvēlēto Kanādas reāliju piemēru etimoloģijas apspriedi. Pētījums rādīja, ka Britu Kolumbija pārsvarā ir attēlota ar sociāliem toponīmiem Lonely Planet ceļvedī. Turklāt, eiropiešu Kanādas …

CanadaValodniecībaGeographical and environmental realiaEtymologyMaterial realiaSocial realia
researchProduct

MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L

2011

SummaryThe histone 3 lysine 79 (H3K79) methyltransferase Dot1l has been implicated in the development of leukemias bearing translocations of the Mixed Lineage Leukemia (MLL) gene. We identified the MLL-fusion targets in an MLL-AF9 leukemia model, and conducted epigenetic profiling for H3K79me2, H3K4me3, H3K27me3, and H3K36me3 in hematopoietic progenitor and leukemia stem cells (LSCs). We found abnormal profiles only for H3K79me2 on MLL-AF9 fusion target loci in LSCs. Inactivation of Dot1l led to downregulation of direct MLL-AF9 targets and an MLL translocation-associated gene expression signature, whereas global gene expression remained largely unaffected. Suppression of MLL translocation-a…

Cancer ResearchOncogene Proteins FusionCellular differentiationApoptosisBiologyMethylationArticleHistonesMice03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesmedicineAnimalsHumansEpigeneticsMyeloid Ecotropic Viral Integration Site 1 ProteinneoplasmsMyeloid Progenitor Cells030304 developmental biologyGene RearrangementHomeodomain Proteins0303 health sciencesLysineMyelodysplastic syndromesCell CycleCell DifferentiationCell BiologyHistone-Lysine N-MethyltransferaseMethyltransferasesMethylationDOT1Lmedicine.diseaseMolecular biologyHematopoiesisNeoplasm Proteins3. Good healthLeukemiaCell Transformation NeoplasticOncologyGenetic Loci030220 oncology & carcinogenesisHistone methyltransferaseCancer researchH3K4me3Protein Processing Post-TranslationalMyeloid-Lymphoid Leukemia ProteinCancer Cell
researchProduct

Erythropoietic cellular analyses in luspatercept-treated lower-risk myelodysplastic syndromes (MDS): Phase 2 PACE-MDS study.

2018

7018Background: Luspatercept (ACE-536) is a TGF-β family ligand trap promoting late-stage erythroid (E) differentiation and increases in hemoglobin. Endpoints of the ongoing, phase 2, open-label st...

Cancer ResearchOncologybusiness.industryPhase (matter)Myelodysplastic syndromesLuspaterceptCancer researchMedicineHemoglobinbusinessLigand (biochemistry)medicine.diseaseLower riskJournal of Clinical Oncology
researchProduct